Format

Send to

Choose Destination
Med Mycol. 2014 Jul;52(5):462-71. doi: 10.1093/mmy/myu018. Epub 2014 Jun 15.

Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis.

Author information

1
Laboratory of Parasitology and Mycology, Grenoble University Hospital, Joseph Fourier University, Grenoble, France BChumpitazi@chu-grenoble.fr.
2
Laboratory of Parasitology and Mycology, Grenoble University Hospital, Joseph Fourier University, Grenoble, France.
3
Clinic of Medical Intensive Care, Grenoble University Hospital, Joseph Fourier University, Grenoble, France.
4
Department of Infectious and Tropical Diseases, Grenoble University Hospital, Joseph Fourier University, Grenoble, France.
5
Department of Hematology, Grenoble University Hospital, Joseph Fourier University, Grenoble, France.
6
Center of Clinic Investigation, Grenoble University Hospital, Joseph Fourier University, Grenoble, France.

Abstract

The gold standard laboratory tests used to diagnose invasive Candida infection (ICI) are based on the in vitro culture of blood or samples from other sterile sites. However, these tests have limited sensitivity (Se) and are generally not diagnostic until late in the infectious process. The Serion Candida mannan kit was evaluated for the diagnosis of ICI at Grenoble University Hospital (France) between 2007 and 2011. The results were then compared with worldwide data published between 1997 and 2011. This retrospective study was based on follow-up from the investigation of 162 patients of whom 91 had proven ICI; 13 had Candida colonization index (CCI) scores ≥0.42, positive mannan tests, with nonconcomitant infections; and 58 had no evidence of Candida infection. Candida albicans, C. glabrata, C. tropicalis, and C. parapsilosis were the etiologic agents in 104 patients. For patients with or without ICI, the 12-week mortality rates were 35/104 (33.7%) and 6/58 (10.3%), respectively. The mannan diagnostic specificity was 51% and Se was 77%. However, in the meta-analysis (n = 1,536), values were 86% and 62%, respectively. Positive mannan test results may appear early (median 6 days) in the development of candidemia and have moderate diagnostic value for ICI, with a negative predictive value of 83%. In patients at risk of ICI with negative candidemia, the combination of Candida mannan test data with a CCI score ≥0.42 may improve the diagnosis of probable ICI.

KEYWORDS:

candidemia; invasive Candida infection; mannan; systematic review

PMID:
24934805
DOI:
10.1093/mmy/myu018
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center